Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ahmed Glaucoma Valve in Aniridia.

Clinical ophthalmology (Auckland, N.Z.)·2025
Same author

Hyperreflective Dots in Central Fovea Visualized by a Novel Application of Visible-Light Optical Coherence Tomography.

Case reports in ophthalmological medicine·2024
Same author

Comparative In Vivo Imaging of Retinal Structures in Tree Shrews, Humans, and Mice.

eNeuro·2024
Same author

Visible-Light Optical Coherence Tomography Fibergraphy of the Tree Shrew Retinal Ganglion Cell Axon Bundles.

IEEE transactions on medical imaging·2024
Same author

Neural damage and neuroprotection with glaucoma development in aniridia.

Current neurobiology·2023
Same author

Characterization of neural damage and neuroinflammation in Pax6 small-eye mice.

Experimental eye research·2023

Related Experiment Video

Updated: May 15, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Screening for glaucoma: rationale and strategies.

John Ryan McManus1, Peter A Netland

  • 1Department of Ophthalmology, University of Virginia School of Medicine, Charlottesville, VA 22908-0715, USA.

Current Opinion in Ophthalmology
|January 5, 2013
PubMed
Summary

Glaucoma screening is most effective when targeting high-risk individuals using specific tests like frequency-doubling technology perimetry. Future automated methods may offer even better detection for this leading cause of vision loss.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Related Experiment Videos

Last Updated: May 15, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Area of Science:

  • Ophthalmology
  • Public Health
  • Diagnostic Technology

Background:

  • Late diagnosis of glaucoma significantly contributes to irreversible vision loss.
  • Glaucoma screening programs aim to detect the disease at earlier, more manageable stages.
  • Understanding the impact of screening location and methodology is crucial for effective public health interventions.

Purpose of the Study:

  • To review the effectiveness of different screening locations for glaucoma.
  • To evaluate various testing strategies employed in glaucoma screening programs.
  • To identify optimal approaches for early glaucoma detection and prevention of vision loss.

Main Methods:

  • Literature review of glaucoma screening programs and testing strategies.
  • Analysis of cost-effectiveness and success rates of different screening approaches.
  • Comparison of diagnostic performance metrics (sensitivity, specificity) for various tests.

Main Results:

  • Screening high-risk populations is more effective than general population screening.
  • Community-based screening often suffers from poor patient follow-up.
  • Simpler screening strategies with fewer tests are generally more effective than multi-test approaches.
  • Frequency-doubling technology (FDT) perimetry demonstrates higher sensitivity and specificity compared to existing tests.
  • Automated optic nerve and retinal nerve fiber layer assessments show promise but require further validation for screening.

Conclusions:

  • Community-based screening of high-risk individuals using FDT perimetry is a viable strategy.
  • Emerging automated structural measurements may enhance future glaucoma screening accuracy.
  • Optimizing screening location and testing methodology is key to reducing glaucoma-related vision loss.